Similar articles for PMID: 21596805

Year	Number of Results
2009	4
2010	6
2011	13
2012	16
2013	21
2014	17
2015	16
2016	13
2017	8
2018	7
2019	8
2020	4
2024	0

1

Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma.

Gupta A, Young RJ, Karimi S, Sood S, Zhang Z, Mo Q, Gutin PH, Holodny AI, Lassman AB. Gupta A, et al. AJNR Am J Neuroradiol. 2011 Aug;32(7):1301-1306. doi: 10.3174/ajnr.A2479. Epub 2011 May 19. AJNR Am J Neuroradiol. 2011. PMID: 21596805 Free PMC article.

2

Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma.

Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC, Lai A, Nghiemphu PL, Mason WP, Cloughesy TF. Ellingson BM, et al. AJNR Am J Neuroradiol. 2014 Apr;35(4):673-9. doi: 10.3174/ajnr.A3748. Epub 2013 Oct 17. AJNR Am J Neuroradiol. 2014. PMID: 24136647 Free PMC article.

3

Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.

Buemi F, Guzzardi G, Del Sette B, Sponghini AP, Matheoud R, Soligo E, Trisoglio A, Carriero A, Stecco A. Buemi F, et al. Neuroradiol J. 2019 Aug;32(4):241-249. doi: 10.1177/1971400919847184. Epub 2019 May 8. Neuroradiol J. 2019. PMID: 31066622 Free PMC article.

4

Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab.

Rahman R, Hamdan A, Zweifler R, Jiang H, Norden AD, Reardon DA, Mukundan S, Wen PY, Huang RY. Rahman R, et al. J Neurooncol. 2014 Aug;119(1):149-58. doi: 10.1007/s11060-014-1464-8. Epub 2014 May 8. J Neurooncol. 2014. PMID: 24805151

5

Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients.

Zhang M, Gulotta B, Thomas A, Kaley T, Karimi S, Gavrilovic I, Woo KM, Zhang Z, Arevalo-Perez J, Holodny AI, Rosenblum M, Young RJ. Zhang M, et al. Neuro Oncol. 2016 May;18(5):735-43. doi: 10.1093/neuonc/nov268. Epub 2015 Nov 3. Neuro Oncol. 2016. PMID: 26538618 Free PMC article.

6

Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.

Ellingson BM, Cloughesy TF, Lai A, Mischel PS, Nghiemphu PL, Lalezari S, Schmainda KM, Pope WB. Ellingson BM, et al. Neuro Oncol. 2011 Oct;13(10):1151-61. doi: 10.1093/neuonc/nor079. Epub 2011 Aug 19. Neuro Oncol. 2011. PMID: 21856685 Free PMC article.

7

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.

Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Lada P, Prados M, Goldin J, Wen PY, Cloughesy T. Pope WB, et al. J Neurooncol. 2012 Jul;108(3):491-8. doi: 10.1007/s11060-012-0847-y. Epub 2012 Mar 18. J Neurooncol. 2012. PMID: 22426926 Free PMC article.

8

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.

Hattingen E, Jurcoane A, Daneshvar K, Pilatus U, Mittelbronn M, Steinbach JP, Bähr O. Hattingen E, et al. Neuro Oncol. 2013 Oct;15(10):1395-404. doi: 10.1093/neuonc/not105. Epub 2013 Aug 7. Neuro Oncol. 2013. PMID: 23925453 Free PMC article.

9

Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma.

Pope WB, Lai A, Mehta R, Kim HJ, Qiao J, Young JR, Xue X, Goldin J, Brown MS, Nghiemphu PL, Tran A, Cloughesy TF. Pope WB, et al. AJNR Am J Neuroradiol. 2011 May;32(5):882-9. doi: 10.3174/ajnr.A2385. Epub 2011 Feb 17. AJNR Am J Neuroradiol. 2011. PMID: 21330401 Free PMC article. Clinical Trial.

10

Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma.

Galla N, Chiang G, Chakraborty S, Singh R, John Tsiouris A, Boockvar J, Kovanlikaya I. Galla N, et al. Neuroradiology. 2017 May;59(5):499-505. doi: 10.1007/s00234-017-1820-4. Epub 2017 Mar 25. Neuroradiology. 2017. PMID: 28343250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year